Published August 11, 2025 | Version v1
Other Open

What is the efficacy and safety of CAR-T for the treatment of refractory B-cell ALL?

Authors/Creators

  • 1. Tripdatabase

Description

CAR-T cell therapies demonstrate promising efficacy in refractory B-cell ALL, achieving high remission rates. Challenges include managing adverse effects like cytokine release syndrome and neurotoxicity. Further studies are needed to evaluate long-term outcomes.

Files

b8b19df3-4b90-46d6-8ae1-e97806ef273f.pdf

Files (18.5 kB)

Name Size Download all
md5:d9be050152083baeee99b50b228fcd3e
18.5 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/efficacy-safety-of-car-t-refractory-b-cell-all-b8b19df3-4b90-46d6-8ae1-e97806ef273f (URL)